NCT03092193
- Conditions
- Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant, Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
- Locations
-
- Bauru School of Dentistry/USP Bauru, São Paulo, Brazil
Clinical trial condition
Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant
Explore clinical trials studying Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant trial results
NCT02378220
- Conditions
- Adverse Drug Events, Adverse Drug Reactions, Chemically-Induced Disorders, +12 more
- Locations
-
- White County Medical Center Home Health Searcy, Arkansas, United States
Completed
YouScript IMPACT Registry
NCT02191358
- Conditions
- Adverse Drug Events, Adverse Drug Reactions, Chemically-Induced Disorders, +13 more
- Locations
-
- Dr. Michael Dao Garden Grove, California, United States
- Kaiser Permanente Colorado Denver, Colorado, United States
- Gill Heart Institute Lexington, Kentucky, United States
- IRC Clinics Towson, Maryland, United States
Related conditions
- Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant (3)
- Adverse Drug Events (2)
- Adverse Drug Reactions (2)
- Chemically-Induced Disorders (2)
- Cytochrome P450 CYP2C19 Enzyme Deficiency (2)
- Cytochrome P450 CYP2C9 Enzyme Deficiency (2)
- Cytochrome P450 CYP2D6 Enzyme Deficiency (2)
- Cytochrome P450 CYP3A Enzyme Deficiency (2)